The document discusses how PepsiCo is shifting its marketing strategy in 2010 to focus on building "movements" rather than singular events. It then summarizes the growth of the #FDASM movement, which started as discussions on social media around FDA guidance and has expanded to include a website, Twitter community, and public engagement on issues in pharmaceutical regulation and communication. Key metrics on the site's growth show it has engaged thousands of unique visitors from over 65 countries through community building and sharing of information online.
This is the annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
DIA Marketing Pharmaceuticals 2015 Leveraging Innovative TechnologiesDale Cooke
This is the slide deck I used to introduce a session on how sponsors of prescription drugs, biologics, and medical devices can take advantage of the newer means that both consumers and healthcare professionals are using to access information, while remaining compliant with FDA regulations.
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
This is the annotated and expanded version of WEGO Health’s presentation at the FDA’s Public Hearing and the Health Activist Social Media Survey results with graphs and explanations.
DIA Marketing Pharmaceuticals 2015 Leveraging Innovative TechnologiesDale Cooke
This is the slide deck I used to introduce a session on how sponsors of prescription drugs, biologics, and medical devices can take advantage of the newer means that both consumers and healthcare professionals are using to access information, while remaining compliant with FDA regulations.
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Presentation given by DJ Edgerton and Guy Mastrion of Pixels & Pills on "What's Next in Social Media for Pharma". The presentation was given at the CBI Social Media Tools Summit and explores cutting edge uses of social media by various pharma/healthcare companies.
Using Interactive Media to Enhance Patient Experience and Create Brand Prefer...John Olson
The widespread adoption of interactive communication technologies has created consumer expectations for information that is personally relevant to them, available on-demand 24/7 via the Internet and increasingly via mobile web. This presentation gives case histories of healthcare organizations that have created interactive tools to meet these expectations, enhance patient experience and promote healing. Additionally, the presentation discusses how interactive media programs can be used to differentiate a provider organization and create competitive advantage.
The impact of social media on the pharmaceutical sectorPaul Grant
A presentation delivered to an audience of medical information, researchers, and clinical trial colleagues from within the pharmaceutical industry at the DIA Clinical Forum in Basel, 12th October 2011
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
Presentation exploring how pharma industry in Brazil and around world are using the web 2.0 to establish interactions with medical community (social networking, twitter, facebook, youtube, linkedin, etc)
Presentation made by Ilyssa Levins at NYU on October 5, 2011 to the Master's Program class of "Public Relations Specialties," taught by PR veteran Saralie Slonsky.
In the 35 slides included here, Ilyssa describes her career path and the industry itself.
She founded her company, Center for Communication Compliance, in 2008 which offers pharmaceutical and medical device companies training and certifications in regulatory compliance.
www.communicationcompliance.com
For more information and specific PR case histories, contact Ilyssa at ilevins@communicationcompliance.com
Class Description: http://www.scps.nyu.edu/course-detail/PRCC1-GC2220/20113/public-relations-specialties
Presentation given by DJ Edgerton and Guy Mastrion of Pixels & Pills on "What's Next in Social Media for Pharma". The presentation was given at the CBI Social Media Tools Summit and explores cutting edge uses of social media by various pharma/healthcare companies.
Using Interactive Media to Enhance Patient Experience and Create Brand Prefer...John Olson
The widespread adoption of interactive communication technologies has created consumer expectations for information that is personally relevant to them, available on-demand 24/7 via the Internet and increasingly via mobile web. This presentation gives case histories of healthcare organizations that have created interactive tools to meet these expectations, enhance patient experience and promote healing. Additionally, the presentation discusses how interactive media programs can be used to differentiate a provider organization and create competitive advantage.
The impact of social media on the pharmaceutical sectorPaul Grant
A presentation delivered to an audience of medical information, researchers, and clinical trial colleagues from within the pharmaceutical industry at the DIA Clinical Forum in Basel, 12th October 2011
Managing knowledge and relationship by web to improve sales efficacy - SFE Su...USP e Plexus
Presentation exploring how pharma industry in Brazil and around world are using the web 2.0 to establish interactions with medical community (social networking, twitter, facebook, youtube, linkedin, etc)
Presentation made by Ilyssa Levins at NYU on October 5, 2011 to the Master's Program class of "Public Relations Specialties," taught by PR veteran Saralie Slonsky.
In the 35 slides included here, Ilyssa describes her career path and the industry itself.
She founded her company, Center for Communication Compliance, in 2008 which offers pharmaceutical and medical device companies training and certifications in regulatory compliance.
www.communicationcompliance.com
For more information and specific PR case histories, contact Ilyssa at ilevins@communicationcompliance.com
Class Description: http://www.scps.nyu.edu/course-detail/PRCC1-GC2220/20113/public-relations-specialties
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
FDASM: The Making of a Social Media Movement
1. The Making of a Movement 3.11.10 | Social Health 2010
2. “ In 2010, each of our brands has a strategy and marketing platform that will be less about a singular event , less about a moment, more about a movement . ” As Frank Cooper, senior VP-chief consumer engagement officer at PepsiCo Americas Beverages
3.
4. What Makes a Movement Work? + + People Purpose Passion
6. #FDASM hashtag Part 15 Public Hearings The Guidance Process The Conversation about safe & effective online communication by pharmaceutical and medical device companies about their products, companies, or services A Movement?
7. How did the FDASM Conversation become a FDASM Movement ?
32. Mobile Version 24/7 Free Chat Room Partner Resources Instructions for Submitting Comments to FDA Video interviews of speakers from hearings Archive of hearing webcast and links to all available presentations Blog Widget with Updated Feeds
33. And most recently… Library of all comments submitted to FDA Interview with the FDA
37. Top 10 Visiting Organizations (min. of 25 visits per organization) AGENCIES PHARMA / MEDICAL OTHER Edelman Genentech FDA Lally McFarland Novartis Univeristy of Michigan Health Ed Abbott Haymarket Media FCB Lilly WebMD CommonHealth Johnson & Johnson Institute of Int. Research Fleishman Hillard GSK Boston University True North Aventis Behring Elsevier Science Publishers Roska Genzyme Ernst & Young Lehman Millet Medtronic John Wiley Publishers WPP Group Bayer Dept. of Veterans Affairs
38.
39. Top 10 Countries Outside of US (US accounts for 83% of all visits)
FDASM started as a twitter hashtag related to the FDA public hearings on the use of internet and Social Media for the promotion of FDA-regulated medical products FDASM evolved to represent the entire journey to guidance, and now… Has become synonymous with the conversation about safe & effective online communications by pharmaceutical and medical device companies
You have the people, the passion, and the purpose – but what was missing was a way to harness this dialogue and channel it – to get everyone moving in the same direction, to create a philosophical platform which would unite and ignite them… in essence, to fuel the fire.
The wind was blowing in the right direction. Hadn’t rained for years. Lots of combustible kindling. Let’s face it, the convergence of social media with an aging population in a new administration that was planning to lead with a strong foot forward in terms of regulations they would deploy to ensure the public health’s safety. You couldn’t have asked for a more perfect storm of elements that were simply waiting for the slightest breath of spark. But that’s not always the case. And when we talk about creating movements in healthcare, we need to fully understand those environmental conditions in order to maximize the probability of creating the kind of firestorm necessary to make a movement take off. if the conditions aren’t right, that doesn’t mean it can’t be done – it simply means that more effort will be required. More nurturing. It’s much easier to capitalize on the energy of a moving object. Obama is a testament to that. For healthcare, that might mean creating awareness, educating and creating an emotional connection between the subject (disease, drug or otherwise) and the person you are trying to “move”. Social Media is a powerful channel for that because you are often already connected to other people, and those people can be the vehicles to connect you to a belief or cause. We have to remember, successful movements, while orchestrated, need to be real and authentic. In the case of FDASM, we had people with true conviction that were willing to carry the torch. They just needed a place to light their flame, and a place where they could let the light of their fires shine. Enter FDASM.COM.
FDASM.COM is an aggregation engine that has helped to capture, harness, and channel the energy of the people who believe the process which the FDA has initiated is relevant, important, and worthy of attention – and that the use of the Internet and Social Media for healthcare communications can be both extremely effective, but also extremely dangerous if mis-managed. But it wasn’t always this way – in fact, to be honest, that’s not what it was designed to be at all!
What FDASM.COM looks like today, and what powers it.
They say “necessity is the mother of invention”… and thank God, because I desperately needed some order in the twitterverse.
I have to be honest with you, no matter how much I consider myself tech-savvy, and some might even call me a twitter power user, I detest almost everything about twitter from a user-experience perspective. It’s convoluted, confusing, and oftentimes downright frustrating. That really hasn’t changed much for me. In fact, my frustration pre-dated all of this FDA-stuff… I had been trying for some time to figure out a way to bring order my universe. That path led me to experiment with different twitter aggregator technologies.
By the time the FDA hearings were announced, I had already created several topic / user / perspective-focused dashboards that aggregated relevant twitter conversations. Most of them were primarily developed to serve me, give me a easy way to see all the conversations of the people or topics I cared about. Sure, I shared these with my peers, but that’s about it. Except for the last one – which is where I explored how to apply this “aggregation” model to healthcare. Diabetes Nest was primarily developed as a tool for twitter-newbies or voyeurs who want to read the conversations or discover who to follow, without having to deal with all the hassles of Twitter and the various client apps.
And what I learned through this process is that aggregation alone can create value. If you really think about it, some of the most valuable services out there created value simply by creating “one-stop-shopping” – whether you’re shopping for concert tickets, food, or information. In my case, I had a very specific need I was trying to meet.
The FDA topic was quite important, and I found the conversations taking place on twitter were far more insightful than anything I could get my hands on in the mainstream media. Not only that, but they were current. So what I needed was a tool that could keep up with the breakneck speed at which information was being produced. Twitter, despite it’s confoundedness, was exactly that tool. But while my organization and many of our clients are quite technology savvy, for a variety of issues Twitter was not a universally-adopted tool. Still, I wanted to make it very easy for those folks to access this information. So taking what I had learned from aggregation in the past, and converging it with a need I had in the present, the site was born.
So after exploring several dozen twitter aggregators I found one I liked on Widgetbox (called Tweetblender), and used it to create a stream based on the hashtag #fdasm, then uploaded it to my scratch pad of experiments called “Ignite Labs” and called it a day. Well, not quite. Now I had another problem to solve, which was the name . Here I was trying to make things easy for everyone, and yet I was going to create yet another name for someone to memorize. I don’t know what I was thinking, I why I would even venture to check if the domain was available, but I thought, let’s just see . In looking back it still didn’t strike me as something that “inspired”… it was more, heh, ok, it makes sense, it’s available, why not? Oh, and lookie-here, so is the username on twitter. It’s a wild, crazy world.
And so it is that FDASM.COM was officially born, October 29, 2009.
When the FDA began sending communications regarding the public hearings, a few things struck me. The information was intended for attendees and presenters – and was being only sent to them. There were lots of little details and valuable information contained in those communications. In addition, I started noticing people asking each other in the twitter stream about details surrounding the hearings – information which I had at my fingertips (in my email box).
So I took the content provided by the FDA, added it FDASM.com, and let people know about it. What happened next was wild. People started tweeting about the resource like crazy. They were praising me and Ignite, and also making suggestions for additional content.
Grateful for the sudden attention (we all have egos), and invigorated by the warm welcome from the twittersphere, I thanked right back and added logos to FDASM.com (“Proud Supporters”) of those tweeting about to the site (with permission of course). Soon after, people saw the logos and asked if they could support the cause too – I instantly obliged – adding their logos, but simply asking for a re-tweet in return (as it seemed unfair to the others I had listed). Ultimately, everyone and anyone was welcome to join the movement! (yes, even competitors). So I told them how to join by creating clear and simple instructions. And the requests poured in.
And poured in…
Shwen suggested I create a badge “I Joined the Movement”, so I did. Eventually making it easy to grab and share.
And people did!
I had momentum, as everything was building towards the hearings. As that happened, people started writing articles and blog posts. Having a difficult time keeping track of it all, I started a google doc. And then it occurred to me, share this with everyone too ! In fact, let them add other articles they find.
And that’s when I also started receiving people’s “sneak peeks” at their FDA testimonies. I asked if I could share those too, they said yes, so I did… Then it occurred to me – let’s invite everyone to share? That way we know if we’re being redundant. That’s when I discovered Health Central was doing the same thing. So we partnered!
As content kept building, people simply found it easier to direct people to FDASM.com rather than providing all the details about the hearings – so they could instead focus on sharing their perspectives – and not regurgitating the facts
The more links and references, the more it becomes the defacto destination for “everything related to the FDA, Internet, and Social Media”. And as the hearings came upon is, it became the destination that was cited by most media outlets covering the story (which of course drew more traffic, more attention, and drove people into the conversation).
THANK THEM – AND THANK THEM OFTEN!
Be prepared, willing, and able to revise and expand upon your theories of what works and what doesn’t!
And most importantly, FAIL FORWARD. It’s the only way to learn, grow, excel, and succeed.